Effectiveness of paliperidone palmitate one-month long-acting injection in obese vs. non-obese patients

被引:0
|
作者
Dorflinger, Charles [1 ]
LeHew, Colleen [1 ]
Carey, Heather [1 ]
Roche-Desilets, Jennifer [1 ]
Burant, Christopher J. [2 ,3 ]
机构
[1] VA Northeast Ohio Healthcare Syst, Pharm Dept, 10701 East Blvd, Cleveland, OH 44106 USA
[2] VA Northeast Ohio Healthcare Syst, Geriatr Res Educ & Clin Ctr, 10701 East Blvd, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 10900 Euclid Ave, Cleveland, OH 44106 USA
关键词
MEDICATION ADHERENCE; SCHIZOPHRENIA; PREVALENCE;
D O I
10.1016/j.comppsych.2021.152269
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
[No abstract available]
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Improvement in outcomes after switching to one-month long-acting injection paliperidone palmitate
    Munoz Negro, J. E.
    Marti Garnica, V.
    Ortega Garcia, M. D.
    Gomez Pasalacqua, R.
    Marin Garcia, S.
    EUROPEAN PSYCHIATRY, 2018, 48 : S196 - S196
  • [2] The effectiveness of the long-acting injections of second generation antipsychotics: A 54-month follow-up study of risperidone long-acting inyection vs paliperidone palmitate one-month formulation
    Navarro Pablo, R.
    Romero Guillena, S. L.
    Gotor Sanchez Luengo, F.
    Plasencia Garcia de Diego, B. O.
    Santamaria Gomez, O.
    EUROPEAN PSYCHIATRY, 2018, 48 : S125 - S126
  • [3] Paliperidone palmitate long-acting injection in schizophrenic patients
    Suarez Gisbert, E.
    EUROPEAN PSYCHIATRY, 2020, 63 : S540 - S540
  • [4] Use of paliperidone palmitate long-acting injection in dual diagnosis patients
    De Cates, A.
    Sridharan, S.
    Ndebele, F.
    Kunar, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S321 - S322
  • [5] COST OF LONG-ACTING RISPERIDONE INJECTION VERSUS LONG-ACTING PALIPERIDONE PALMITATE IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Ivakhnenko, O.
    Khailov, P.
    Tsfasman, F. M.
    Krysanov, I
    Zorin, N.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
  • [6] Effectiveness and Predictors of Continuation of Paliperidone Palmitate Long-Acting Injection Treatment A 12-Month Naturalistic Cohort Study
    Whale, Richard
    Pereira, Marco
    Cuthbert, Sharon
    Fialho, Renata
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (05) : 591 - 595
  • [7] Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection
    Mesones-Peral, Jesus E.
    Gurillo-Munoz, Pedro
    Paz Sanchez-Sicilia, Mari
    Miller, Adam
    Grinant-Fernandez, Alejandra
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2017, 10 (01): : 33 - 37
  • [8] Effectiveness of long-acting paliperidone palmitate in borderline personality disorder
    Palomares, Nerea
    Montes, Ana
    Diaz-Marsa, Marina
    Carrasco, Jose L.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (06) : 338 - 341
  • [9] Effectiveness of paliperidone long-acting injection in clinical practice
    Deslandes, Paul Nicholas
    Ward, Elan Haf
    Norris, Kathryn
    Sewell, Robert David
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2018, 8 (05) : 139 - 145
  • [10] Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
    Yoshiteru Takekita
    Yosuke Koshikawa
    Chiara Fabbri
    Shiho Sakai
    Naotaka Sunada
    Ai Onohara
    Keiichiro Nishida
    Masafumi Yoshimura
    Masaki Kato
    Alessandro Serretti
    Toshihiko Kinoshita
    BMC Psychiatry, 16